National Stroke Foundation

Condylox Gel 0.5% (pokofilox)

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Approval Status:

Approved March 1997

Specific Treatments:

external genital and perianal warts

General Information

Condylox Gel 0.5% (pokofilox) has been approved for the treatment of external genital and perianal warts (condyloma acuminata). It is believed that Condylox Gel offers two important advancements over the topical solution: easy, finger-tip application and an expanded perianal wart indication.